Patterns and Determinants of Blood and Blood Products Transfusion in Neonate: An Experience of Single Institute

Numan Nafie Hameed; Hiba Khalil Ameen; Safa Faraj

doi:10.3889/oamjms.2022.8641

Authors

Numan Nafie Hameed Department of Pediatrics, College of Medicine, Baghdad University, Baghdad, Iraq; Department of Pediatrics, Children Welfare Teaching Hospital, Medical City Complex Baghdad, Baghdad, Iraq
Hiba Khalil Ameen Department of Pediatrics, Children Welfare Teaching Hospital, Medical City Complex Baghdad, Baghdad, Iraq
Safa Faraj Department of Pediatrics, College of Medicine, Wasit University, Children Welfare Teaching Hospital, Kut, Iraq https://orcid.org/0000-0002-4126-055X

DOI:

https://doi.org/10.3889/oamjms.2022.8641

Keywords:

Neonate, Blood products transfusion, Gestational age

Abstract

BACKGROUND: Neonates requiring intensive care are among the most frequently transfused group of patients. Indications for blood transfusion in neonates could be physiological or pathological. However, despite frequent blood transfusions in neonates in Iraq, there is a paucity of studies on its indications and patterns among neonates in our setting.

AIM: The aim of the study is to shed light on the details of giving blood and blood products in the unit of neonate in Children Welfare Teaching hospital, Baghdad and the justifications for giving and its complication.

PATIENTS AND METHODS: A descriptive study (cross-section study) includes all neonates admitted to neonatal care unit in Children Welfare Teaching Hospital. The study includes a group of newborns who were blood transfused during their admission to hospital, over a period of 6 months from October 1, 2019 to March 30, 2020. All data were collected from each patient and recorded in predesigned forma, these data include patient’s clinical data and analyzed using descriptive statistics.

RESULTS: A total number of cases admitted over a period of 6 months were 862. One hundred and forty neonates received blood and its products transfusion, (61.4%) were male and (38.6%) were female, (62.9%) received packed red blood cells (PRBCs) followed by (18.6%) received exchange transfusion, (11.4%) received Fresh frozen plasma and (7.1%) received platelets. Most neonates received blood products transfused at (3–4) weeks. Post-natal age and were term babies (37–41) weeks. Gestational age mostly received PRBCs.

CONCLUSIONS: Most neonates with a high rate of blood and blood product transfusion were males, term, need assistant ventilation, and transfused at 3–4 weeks postnatal age.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Author Biographies

Numan Nafie Hameed , Department of Pediatrics, College of Medicine, Baghdad University, Baghdad, Iraq; Department of Pediatrics, Children Welfare Teaching Hospital, Medical City Complex Baghdad, Baghdad, Iraq

Hiba Khalil Ameen, Department of Pediatrics, Children Welfare Teaching Hospital, Medical City Complex Baghdad, Baghdad, Iraq

Safa Faraj, Department of Pediatrics, College of Medicine, Wasit University, Children Welfare Teaching Hospital, Kut, Iraq

References

Davies P, Robertson S, Hegde S, Greenwood R, Massey E, Davis P. Calculating the required transfusion volume in children. Transfusion. 2007;47(2):212-6. https://doi.org/10.1111/j.1537-2995.2007.01091.x PMid:17302766 DOI: https://doi.org/10.1111/j.1537-2995.2007.01091.x

Goel R, Josephson CD. Recent advances in transfusions in neonates/infants. F1000Res. 2018;7:F1000. https://doi.org/10.12688/f1000research.13979.1 PMid:29904575 DOI: https://doi.org/10.12688/f1000research.13979.1

Keir AK, Yang J, Harrison A, Pelausa E, Shah PS, Network CN. Temporal changes in blood product usage in preterm neonates born at less than 30 weeks’ gestation in Canada. Transfusion. 2015;55(6):1340-6. https://doi.org/10.1111/trf.12998 PMid:25652740 DOI: https://doi.org/10.1111/trf.12998

Alverson DC. The physiologic impact of anemia in the neonate. Clin Perinatol. 1995;22(3):609-25. PMid:8521684 DOI: https://doi.org/10.1016/S0095-5108(18)30271-9

Banerjee J, Asamoah FK, Singhvi D, Kwan AW, Morris JK, Aladangady N. Haemoglobin level at birth is associated with short term outcomes and mortality in preterm infants. BMC Med. 2015;13(1):16. https://doi.org/https://doi.org/10.1186/s12916-014-0247-6 PMid:25622597 DOI: https://doi.org/10.1186/s12916-014-0247-6

Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F96-100. https://doi.org/10.1136/fn.84.2.f96 PMid:11207224 DOI: https://doi.org/10.1136/fn.84.2.F96

Lopriore E. Updates in red blood cell and platelet transfusions in preterm neonates. Am J Perinatol. 2019;36(S02):S37-40. https://doi.org/10.1055/s-0039-1691775 PMid:31238357 DOI: https://doi.org/10.1055/s-0039-1691775

Ogunlesi TA, Ogunfowora OB, Osinupebi O, Olanrewaju DM. Changing trends in newborn sepsis in Sagamu, Nigeria: Bacterial aetiology, risk factors and antibiotic susceptibility. J Paediatr Child Health. 2011;47(1‐2):5-11. https://doi.org/10.1111/j.1440-1754.2010.01882.x PMid:20973858 DOI: https://doi.org/10.1111/j.1440-1754.2010.01882.x

Kotowski M, Litwinska Z, Klos P, Pius-Sadowska E, Zagrodnik- Ulan E, Ustianowski P, et al. Autologous cord blood transfusion in preterm infants-could its humoral effect be the kez to control prematurity-related complications? A preliminary study. J Physiol Pharmacol. 2017;68(6):921-7. PMid:29550804

Patel RM, Hendrickson JE, Nellis ME, Birch R, Goel R, Karam O, et al. Variation in neonatal transfusion practice. J Pediatr. 2021;235:92-9.e4. https://doi.org/10.1016/j.jpeds.2021.04.002 PMid:33836184 DOI: https://doi.org/10.1016/j.jpeds.2021.04.002

Elgendy MM, Durgham R, Othman HF, Heis F, Abu-Shaweesh G, Saker F, et al. Platelet transfusion and outcomes of preterm infants: A cross-sectional study. Neonatology. 2021;118:1-9. https://doi.org/10.1159/000515900 PMid:33975321 DOI: https://doi.org/10.1159/000515900

Whyte RK, Jefferies AL, Canadian Paediatric Society, Fetus and Newborn Committee. Red blood cell transfusion in newborn infants. Paediatr Child Health. 2014;19(4):213-22. https://doi.org/10.1093/pch/19.4.213 PMid:24855419 DOI: https://doi.org/10.1093/pch/19.4.213

Bell EF. Transfusion thresholds for preterm infants: How low should we go? J Pediatr. 2006;149(3):287-9. https://doi.org/10.1016/j.jpeds.2006.06.033 PMid:16939732 DOI: https://doi.org/10.1016/j.jpeds.2006.06.033

Carson JL, Stanworth SJ, Alexander JH, Roubinian N, Fergusson DA, Triulzi DJ, et al. Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease. Am Heart J. 2018;200:96-101. https://doi.org/10.1016/j.ahj.2018.04.007 PMid:29898855 DOI: https://doi.org/10.1016/j.ahj.2018.04.007

Pedrosa AK, Pinto FJ, Lins LD, Deus GM. Blood transfusion reactions in children: Associated factors. J Pediatr (Rio J). 2013;89(4):400-6. https://doi.org/10.1016/j.jped.2012.12.009 PMid:23791024 DOI: https://doi.org/10.1016/j.jped.2012.12.009

Bell EF. Red cell transfusion thresholds for preterm infants: Finally some answers. Arch Dis Child Fetal Neonatal Ed. 2022;107(2):126-30. https://doi.org/10.1136/archdischild-2020-320495 PMid:33906941 DOI: https://doi.org/10.1136/archdischild-2020-320495